Abstract
Turner syndrome (TS) is one of the most common human chromosome anomalies. It occurs in approximately 1:2,000 female live births regardless of ethnic background. Girls with TS have an abnormal or missing X chromosome that causes short stature and may cause lymphedema, cardiac abnormalities, gonadal dysgenesis, dysmorphic features, nonverbal learning disabilities, and other problems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet. 1991;87:81–3.
Bondy CA. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92:10–25.
Sybert VP, McCauley E. Turner’s syndrome. N Engl J Med. 2004;351:1227–38.
Gravholt CH. Epidemiology of Turner syndrome. Lancet Oncol. 2008;9:193–5.
Hook EB, Warburton D. The distribution of chromosomal genotypes associated with Turner’s syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet. 1983;64:24–7.
Neely EK, Rosenfeld RG. Phenotypic correlations of X-chromosome loss. In: Wachtel SS, editor. Molecular genetics of sex determination. San Diego: Academic; 1994. p. 311–39.
Leonova J, Hanson C. A study of 45, X/46, XX mosaicism in Turner syndrome females: a novel primer pair for the (CAG)n repeat within the androgen receptor gene. Hereditas. 1999;131:87–92.
Berletch JB, Yang F, Disteche CM. Escape from X inactivation in mice and humans. Genome Biol. 2010;11:213.
Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005;434:400–4.
Clement-Jones M, Schiller S, Rao E, et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet. 2000;9:695–702.
Marchini A, Rappold G, Schneider KU. SHOX at a glance: from gene to protein. Arch Physiol Biochem. 2007;113:116–23.
Blaschke RJ, Rappold G. The pseudoautosomal regions, SHOX and disease. Curr Opin Genet Dev. 2006;16:233–9.
Marchini A, Hacker B, Marttila T, et al. BNP is a transcriptional target of the short stature homeobox gene SHOX. Hum Mol Genet. 2007;16: 3081–7.
Blaschke RJ, Rappold GA. SHOX: growth, Leri-Weill and Turner syndromes. Trends Endocrinol Metab. 2000;11:227–30.
Ellison JW, Wardak Z, Young MF, Gehron RP, Laig-Webster M, Chiong W. PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum Mol Genet. 1997;6:1341–7.
Kajii T, Ferrier A, Niikawa N, et al. Anatomic and chromosomal anomalies in 639 spontaneous abortuses. Hum Genet. 1980;55:87–98.
Barr Jr M, Oman-Ganes L. Turner syndrome morphology and morphometrics: cardiac hypoplasia as a cause of midgestation death. Teratology. 2002;66:65–72.
Urbach A, Benvenisty N. Studying early lethality of 45, XO (Turner’s syndrome) embryos using human embryonic stem cells. PLoS One. 2009;4:e4175.
Loscalzo ML, Van PL, Ho VB, et al. Association between fetal lymphedema and congenital cardiovascular defects in Turner syndrome. Pediatrics. 2005;115:732–5.
Zinn AR, Roeltgen D, Stefanatos G, et al. A Turner syndrome neurocognitive phenotype maps to Xp22.3. J Soc Gynecol Investig. 2001;8:S34–6.
Modi DN, Sane S, Bhartiya D. Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Mol Hum Reprod. 2003;9:219–25.
Simpson JL, Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet. 1999;89: 186–200.
Speed RM. Oocyte development in XO foetuses of man and mouse: the possible role of heterologous X-chromosome pairing in germ cell survival. Chromosoma. 1986;94:115–24.
Tsezou A, Hadjiathanasiou C, Gourgiotis D, et al. Molecular genetics of Turner syndrome: correlation with clinical phenotype and response to growth hormone therapy. Clin Genet. 1999;56:441–6.
Bondy CA, Matura LA, Wooten N, Troendle J, Zinn AR, Bakalov VK. The physical phenotype of girls and women with Turner syndrome is not X-imprinted. Hum Genet. 2007;121:469–74.
Skuse DH, James RS, Bishop DV, et al. Evidence from Turner’s syndrome of an imprinted X-linked locus affecting cognitive function. Nature. 1997;387:705–8.
Ross J, Zinn A, McCauley E. Neurodevelopmental and psychosocial aspects of Turner syndrome. Ment Retard Dev Disabil Res Rev. 2000;6:135–41.
Raefski AS, O’Neill MJ. Identification of a cluster of X-linked imprinted genes in mice. Nat Genet. 2005;37:620–4.
Davies W, Isles A, Smith R, et al. Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects on cognitive function in mice. Nat Genet. 2005;37:625–9.
Migeon BR, Luo S, Stasiowski BA, et al. Deficient transcription of XIST from tiny ring X chromosomes in females with severe phenotypes. Proc Natl Acad Sci U S A. 1993;90:12025–9.
Turner C, Dennis NR, Skuse DH, Jacobs PA. Seven ring (X) chromosomes lacking the XIST locus, six with an unexpectedly mild phenotype. Hum Genet. 2000;106:93–100.
Lippe BM, Saenger PH. Turner syndrome. In: Sperling MA, editor. Pediatric endocrinology. 2nd ed. Philadelphia, PA: Saunders; 2002. p. 519–64.
Massa GG, Vanderschueren-Lodeweyckx M. Age and height at diagnosis in Turner syndrome: influence of parental height. Pediatrics. 1991;88:1148–52.
Savendahl L, Davenport ML. Delayed diagnoses of Turner’s syndrome: proposed guidelines for change. J Pediatr. 2000;137:455–9.
Bekker MN, van den Akker NM, de Mooij YM, Bartelings MM, van Vugt JM, Gittenberger-de Groot AC. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema. Reprod Sci. 2008;15:295–304.
Bellini C, Di BE, Boccardo F, et al. The role of lymphoscintigraphy in the diagnosis of lymphedema in Turner syndrome. Lymphology. 2009;42:123–9.
Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics. 1998; 101:E11.
Mortensen KH, Hjerrild BE, Andersen NH, et al. Abnormalities of the major intrathoracic arteries in Turner syndrome as revealed by magnetic resonance imaging. Cardiol Young. 2010;20:191–200.
Kim HK, Gottliebson W, Hor K, et al. Cardiovascular anomalies in Turner syndrome: spectrum, prevalence, and cardiac MRI findings in a pediatric and young adult population. AJR Am J Roentgenol. 2011;196:454–60.
Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner’s syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr. 1998;133:688–92.
Gravholt CH, Landin-Wilhelmsen K, Stochholm K, et al. Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol Young. 2006;16:430–6.
Bordeleau L, Cwinn A, Turek M, Barron-Klauninger K, Victor G. Aortic dissection and Turner’s syndrome: case report and review of the literature. J Emerg Med. 1998;16:593–6.
Lin AE, Lippe B, Rosenfeld RG. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics. 1998; 102:e12.
Elsheikh M, Casadei B, Conway GS, Wass JA. Hypertension is a major risk factor for aortic root dilatation in women with Turner’s syndrome. Clin Endocrinol (Oxf). 2001;54:69–73.
Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. Blood pressure and Turner syndrome. Clin Endocrinol (Oxf). 2000;52:363–70.
Sybert VP. Adult height in Turner syndrome with and without androgen therapy. J Pediatr. 1984;104: 365–9.
Ranke MB, Pfluger H, Rosendahl W, et al. Turner syndrome: spontaneous growth in 150 cases and review of the literature. Eur J Pediatr. 1983;141: 81–8.
Rochiccioli P, David M, Malpuech G, et al. Study of final height in Turner’s syndrome: ethnic and genetic influences. Acta Paediatr. 1994;83:305–8.
Even L, Cohen A, Marbach N, et al. Longitudinal analysis of growth over the first 3 years of life in Turner’s syndrome. J Pediatr. 2000;137:460–4.
Davenport ML, Punyasavatsut N, Gunther D, Savendahl L, Stewart PW. Turner syndrome: a pattern of early growth failure. Acta Paediatr Suppl. 1999;88:118–21.
Karlberg J, Albertsson-Wikland K, Nilsson KO, Ritzen EM, Westphal O. Growth in infancy and childhood in girls with Turner’s syndrome. Acta Paediatr Scand. 1991;80:1158–65.
Mathisen B, Reilly S, Skuse D. Oral-motor dysfunction and feeding disorders of infants with Turner syndrome. Dev Med Child Neurol. 1992;34: 141–9.
Perkiomaki MR, Alvesalo L. Palatine ridges and tongue position in Turner syndrome subjects. Eur J Orthod. 2008;30:163–8.
Gravholt CH, Weis NR. Reference values for body proportions and body composition in adult women with Ullrich-Turner syndrome. Am J Med Genet. 1997;72:403–8.
Elder DA, Roper MG, Henderson RC, Davenport ML. Kyphosis in a Turner syndrome population. Pediatrics. 2002;109:e93.
Even L, Bronstein V, Hochberg Z. Bone maturation in girls with Turner’s syndrome. Eur J Endocrinol. 1998;138:59–62.
Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol. 1998;51:147–58.
Bakalov VK, Axelrod L, Baron J, et al. Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab. 2003;88: 5717–22.
Bakalov VK, Bondy CA. Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord. 2008;9:145–51.
Rongen-Westerlaken C, Van Den Born E, Prahl-Andersen B, et al. Shape of the craniofacial complex in children with Turner syndrome. J Biol Buccale. 1992;20:185–90.
Laine T, Alvesalo L. Size of the alveolar arch of the mandible in relation to that of the maxilla in 45, X females. J Dent Res. 1986;65:1432–4.
Midtbo M, Halse A. Skeletal maturity, dental maturity, and eruption in young patients with Turner syndrome. Acta Odontol Scand. 1992;50:303–12.
Szilagyi A, Keszthelyi G, Nagy G, Madlena M. Oral manifestations of patients with Turner syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:577–84.
Faggella A, Guadagni MG, Cocchi S, Tagariello T, Piana G. Dental features in patients with Turner syndrome. Eur J Paediatr Dent. 2006;7:165–8.
Townsend G, Jensen BL, Alvesalo L. Reduced tooth size in 45, X (Turner syndrome) females. Am J Phys Anthropol. 1984;65:367–71.
Sculerati N, Ledesma-Medina J, Finegold DN, Stool SE. Otitis media and hearing loss in Turner syndrome. Arch Otolaryngol Head Neck Surg. 1990;116:704–7.
Stenberg AE, Nylen O, Windh M, Hultcrantz M. Otological problems in children with Turner’s syndrome. Hear Res. 1998;124:85–90.
Hederstierna C, Hultcrantz M, Rosenhall U. A longitudinal study of hearing decline in women with Turner syndrome. Acta Otolaryngol. 2009;129:1434–41.
Roush J, Davenport ML, Carlson-Smith C. Early-onset sensorineural hearing loss in a child with Turner syndrome. J Am Acad Audiol. 2000;11:446–53.
Gungor N, Boke B, Belgin E, Tuncbilek E. High frequency hearing loss in Ullrich-Turner syndrome. Eur J Pediatr. 2000;159:740–4.
Chrousos GA, Ross JL, Chrousos G, et al. Ocular findings in Turner syndrome. A prospective study. Ophthalmology. 1984;91:926–8.
Denniston AK, Butler L. Ophthalmic features of Turner’s syndrome. Eye (Lond). 2004;18:680–4.
Lloyd IC, Haigh PM, Clayton-Smith J, et al. Anterior segment dysgenesis in mosaic Turner syndrome. Br J Ophthalmol. 1997;81:639–43.
Bilge I, Kayserili H, Emre S, et al. Frequency of renal malformations in Turner syndrome: analysis of 82 Turkish children. Pediatr Nephrol. 2000;14:1111–4.
Lippe B, Geffner ME, Dietrich RB, Boechat MI, Kangarloo H. Renal malformations in patients with Turner syndrome: imaging in 141 patients. Pediatrics. 1988;82:852–6.
El-Mansoury M, Berntorp K, Bryman I, et al. Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. Clin Endocrinol (Oxf). 2008;68:485–90.
Roulot D, Degott C, Chazouilleres O, et al. Vascular involvement of the liver in Turner’s syndrome. Hepatology. 2004;39:239–47.
Larizza D, Locatelli M, Vitali L, et al. Serum liver enzymes in Turner syndrome. Eur J Pediatr. 2000;159:143–8.
Bonamico M, Bottaro G, Pasquino AM, et al. Celiac disease and Turner syndrome. J Pediatr Gastroenterol Nutr. 1998;26:496–9.
Keating JP, Ternberg JL, Packman R. Association of Crohn disease and Turner syndrome. J Pediatr. 1978;92:160–1.
Weiss SW. Pedal hemangioma (venous malformation) occurring in Turner’s syndrome: an additional manifestation of the syndrome. Hum Pathol. 1988;19:1015–8.
Eroglu Y, Emerick KM, Chou PM, Reynolds M. Gastrointestinal bleeding in Turner’s syndrome: a case report and literature review. J Pediatr Gastroenterol Nutr. 2002;35:84–7.
Becker B, Jospe N, Goldsmith LA. Melanocytic nevi in Turner syndrome. Pediatr Dermatol. 1994;11:120–4.
Wyatt D. Melanocytic nevi in children treated with growth hormone. Pediatrics. 1999;104:1045–50.
Zvulunov A, Wyatt DT, Laud PW, Esterly NB. Influence of genetic and environmental factors on melanocytic naevi: a lesson from Turner’s syndrome. Br J Dermatol. 1998;138:993–7.
Gibbs P, Brady BM, Gonzalez R, Robinson WA. Nevi and melanoma: lessons from Turner’s syndrome. Dermatology. 2001;202:1–3.
Noguchi H, Kayashima K, Nishiyama S, Ono T. Two cases of pilomatrixoma in Turner’s syndrome. Dermatology. 1999;199:338–40.
Lowenstein EJ, Kim KH, Glick SA. Turner’s syndrome in dermatology. J Am Acad Dermatol. 2004;50:767–76.
Larralde M, Gardner SS, Torrado MV, et al. Lymphedema as a postulated cause of cutis verticis gyrata in Turner syndrome. Pediatr Dermatol. 1998;15:18–22.
Larizza D, Calcaterra V, Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun. 2009;33:25–30.
Hayward PA, Satsangi J, Jewell DP. Inflammatory bowel disease and the X chromosome. QJM. 1996;89:713–8.
Medeiros CC, Marini SH, Baptista MT, Guerra Jr G, Maciel-Guerra AT. Turner’s syndrome and thyroid disease: a transverse study of pediatric patients in Brazil. J Pediatr Endocrinol Metab. 2000;13:357–62.
Mortensen KH, Cleemann L, Hjerrild BE, et al. Increased prevalence of autoimmunity in Turner syndrome—influence of age. Clin Exp Immunol. 2009;156:205–10.
Zulian F, Schumacher HR, Calore A, Goldsmith DP, Athreya BH. Juvenile arthritis in Turner’s syndrome: a multicenter study. Clin Exp Rheumatol. 1998;16:489–94.
Blackett PR, Rundle AC, Frane J, Blethen SL. Body mass index (BMI) in Turner Syndrome before and during growth hormone (GH) therapy. Int J Obes Relat Metab Disord. 2000;24:232–5.
Caprio S, Boulware S, Diamond M, et al. Insulin resistance: an early metabolic defect of Turner’s syndrome. J Clin Endocrinol Metab. 1991;72:832–6.
Gravholt CH, Naeraa RW, Nyholm B, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner’s syndrome. The impact of sex hormone replacement. Diabetes Care. 1998;21:1062–70.
Bakalov VK, Cooley MM, Quon MJ, et al. Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab. 2004;89:3516–20.
Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner’s syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinol Metab. 1997;82: 1810–3.
Crosignani PG, Rubin BL. Optimal use of infertility diagnostic tests and treatments. The ESHRE Capri Workshop Group. Hum Reprod. 2000;15:723–32.
Tarani L, Lampariello S, Raguso G, et al. Pregnancy in patients with Turner’s syndrome: six new cases and review of literature. Gynecol Endocrinol. 1998;12:83–7.
Conte FA, Grumbach MM, Kaplan SL. A diphasic pattern of gonadotropin secretion in patients with the syndrome of gonadal dysgenesis. J Clin Endocrinol Metab. 1975;40:670–4.
Chrysis D, Spiliotis BE, Stene M, Cacciari E, Davenport ML. Gonadotropin secretion in girls with turner syndrome measured by an ultrasensitive immunochemiluminometric assay. Horm Res. 2006;65:261–6.
Gravholt CH, Naeraa RW, Andersson AM, Christiansen JS, Skakkebaek NE. Inhibin A and B in adolescents and young adults with Turner’s syndrome and no sign of spontaneous puberty. Hum Reprod. 2002;17:2049–53.
Wilson CA, Heinrichs C, Larmore KA, et al. Estradiol levels in girls with Turner’s syndrome compared to normal prepubertal girls as determined by an ultrasensitive assay. J Pediatr Endocrinol Metab. 2003;16:91–6.
Sehested A, Juul AA, Andersson AM, et al. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab. 2000;85:1634–40.
Chellakooty M, Schmidt IM, Haavisto AM, et al. Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab. 2003;88:3515–20.
Hagen CP, Aksglaede L, Sorensen K, et al. Serum levels of anti-Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab. 2010;95:5003–10.
Sutton EJ, McInerney-Leo A, Bondy CA, Gollust SE, King D, Biesecker B. Turner syndrome: four challenges across the lifespan. Am J Med Genet A. 2005;139A:57–66.
Oktay K, Rodriguez-Wallberg KA, Sahin G. Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure. Fertil Steril. 2010;94:753–9.
Brant WO, Rajimwale A, Lovell MA, et al. Gonadoblastoma and Turner syndrome. J Urol. 2006;175:1858–60.
Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev. 2006;27:468–84.
Gravholt CH, Fedder J, Naeraa RW, Muller J. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab. 2000;85:3199–202.
Rovet J. Turner syndrome: a review of genetic and hormonal influences on neuropsychological functioning. Neuropsychol Dev Cogn C Child Neuropsychol. 2004;10:262–79.
Ross J, Roeltgen D, Zinn A. Cognition and the sex chromosomes: studies in Turner syndrome. Horm Res. 2006;65:47–56.
Kesler SR. Turner syndrome. Child Adolesc Psychiatr Clin N Am. 2007;16:709–22.
Rovet JF. The cognitive and neuropsychological characteristics of females with Turner Syndrome. In: Berch DB, Berger BG, editors. Sex chromosome abnormalities and human behavior. Boulder, CO: Western Press; 1990. p. 38–77.
Rovet JF. The psychoeducational characteristics of children with Turner syndrome. J Learn Disabil. 1993;26:333–41.
Mazzocco MM. A process approach to describing mathematics difficulties in girls with Turner syndrome. Pediatrics. 1998;102:492–6.
El Abd S, Patton MA, Turk J, Hoey H, Howlin P. Social, communicational, and behavioral deficits associated with ring X turner syndrome. Am J Med Genet. 1999;88:510–6.
Donnelly SL, Wolpert CM, Menold MM, et al. Female with autistic disorder and monosomy X (Turner syndrome): parent-of-origin effect of the X chromosome. Am J Med Genet. 2000;96:312–6.
Blatt J, Olshan AF, Lee PA, Ross JL. Neuroblastoma and related tumors in Turner’s syndrome. J Pediatr. 1997;131:666–70.
Wolff DJ, Van Dyke DL, Powell CM. Laboratory guideline for Turner syndrome. Genet Med. 2010;12:52–5.
Gicquel C, Gaston V, Cabrol S, Le BY. Assessment of Turner’s syndrome by molecular analysis of the X chromosome in growth-retarded girls. J Clin Endocrinol Metab. 1998;83:1472–6.
Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab. 2010;95: 1487–95.
Davenport ML. Turner syndrome. In: Cassidy SB, Allanson JE, editors. Management of genetic syndromes. 3rd ed. Hoboken: Wiley; 2010. p. 847–69.
Lerner R. What’s new in lymphedema therapy in America? Int J Angiol. 1998;7:191–6.
Bernas MJ, Witte CL, Witte MH. The diagnosis and treatment of peripheral lymphedema: draft revision of the 1995 Consensus Document of the International Society of Lymphology Executive Committee for discussion at the September 3-7, 2001, XVIII International Congress of Lymphology in Genoa, Italy. Lymphology. 2001;34:84–91.
Thomson SJ, Tanner NS, Mercer DM. Web neck deformity; anatomical considerations and options in surgical management. Br J Plast Surg. 1990;43:94–100.
The Practice Committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril. 2005;83:1074–5.
Davenport ML, Punyasavatsut N, Stewart PW, Gunther DF, Savendahl L, Sybert VP. Growth failure in early life: an important manifestation of Turner syndrome. Horm Res. 2002;57:157–64.
Rongen-Westerlaken C, Corel L, Van den Broeck J, et al. Reference values for height, height velocity and weight in Turner’s syndrome. Swedish Study Group for GH treatment. Acta Paediatr. 1997;86: 937–42.
Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child. 1985;60:932–5.
Saenger P. Growth-promoting strategies in Turner’s syndrome. J Clin Endocrinol Metab. 1999;84:4345–8.
van Pareren YK, Duivenvoorden HJ, Slijper FM, Koot HM, Drop SL, de Muinck Keizer-Schrama SM. Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome. Horm Res. 2005;63:238–44.
Stephure DK. Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab. 2005;90:3360–6.
Ross JL, Quigley CA, Cao D, et al. Growth hormone plus childhood low-dose estrogen in Turner’s syndrome. N Engl J Med. 2011;364:1230–42.
Menke LA, Sas TC, de Muinck Keizer-Schrama SM, et al. Efficacy and safety of oxandrolone in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab. 2010;95:1151–60.
Zeger MP, Shah K, Kowal K, Cutler Jr GB, Kushner H, Ross JL. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome. Horm Res Paediatr. 2011;75:38–46.
Carel JC, Mathivon L, Gendrel C, Chaussain JL. Growth hormone therapy for Turner syndrome: evidence for benefit. Horm Res. 1997;48 Suppl 5:31–4.
Donaldson MD. Growth hormone therapy in Turner syndrome—current uncertainties and future strategies. Horm Res. 1997;48 Suppl 5:35–44.
Haeusler G, Schmitt K, Blumel P, Plochl E, Waldhor T, Frisch H. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height. Acta Paediatr. 1996;85:1408–14.
Ranke MB, Lindberg A, Ferrandez LA, et al. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Pediatr Res. 2007;61:105–10.
Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, et al. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J Clin Endocrinol Metab. 1999;84:4607–12.
Davenport ML, Crowe BJ, Travers SH, et al. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007;92:3406–16.
Reiter EO, Attie KM, Moshang Jr T, et al. A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency. J Clin Endocrinol Metab. 2001;86:4700–6.
Carel JC, Ecosse E, Bastie-Sigeac I, et al. Quality of life determinants in young women with turner’s syndrome after growth hormone treatment: results of the StaTur population-based cohort study. J Clin Endocrinol Metab. 2005;90:1992–7.
Carel JC, Mathivon L, Gendrel C, Ducret JP, Chaussain JL. Near normalization of final height with adapted doses of growth hormone in Turner’s syndrome. J Clin Endocrinol Metab. 1998;83:1462–6.
Rosenfeld RG, Frane J, Attie KM, et al. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr. 1992;121:49–55.
Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. J Clin Endocrinol Metab. 2000;85:2439–45.
van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, et al. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88:1119–25.
Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang Jr T, Root AW. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J Clin Endocrinol Metab. 2005;90:6424–30.
Sas TC, Gerver WJ, de Bruin R, et al. Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial. J Clin Endocrinol Metab. 1999;84:4622–8.
Sato N, Nimura A, Horikawa R, Katumata N, Tanae A, Tanaka T. Bone mineral density in Turner syndrome: relation to GH treatment and estrogen treatment. Endocr J. 2000;47(Suppl):S115–9.
Rubin K. Turner syndrome and osteoporosis: mechanisms and prognosis. Pediatrics. 1998; 102(2Pt3): 481–5.
Hass AD, Simmons KE, Davenport ML, Proffit WR. The effect of growth hormone on craniofacial growth and dental maturation in Turner syndrome. Angle Orthod. 2001;71:50–9.
Rongen-Westerlaken C, Van Den Born E, Prahl-Andersen B, et al. Effect of growth hormone treatment on craniofacial growth in Turner’s syndrome. Acta Paediatr. 1993;82:364–8.
Ross JL, Feuillan P, Kushner H, Roeltgen D, Cutler Jr GB. Absence of growth hormone effects on cognitive function in girls with Turner syndrome. J Clin Endocrinol Metab. 1997;82:1814–7.
Huisman J, Slijper FM, Sinnema G, et al. Psychosocial effects of two years of human growth hormone treatment in Turner syndrome. The Dutch Working Group: Psychologists and Growth Hormone. Horm Res. 1993;39 Suppl 2:56–9.
Siegel PT, Clopper R, Stabler B. The psychological consequences of Turner syndrome and review of the National Cooperative Growth Study psychological substudy. Pediatrics. 1998;102:488–91.
Rovet J, Holland J. Psychological aspects of the Canadian randomized controlled trial of human growth hormone and low-dose ethinyl oestradiol in children with Turner syndrome. The Canadian Growth Hormone Advisory Group. Horm Res. 1993;39 Suppl 2:60–4.
Amundson E, Boman UW, Barrenas ML, Bryman I, Landin-Wilhelmsen K. Impact of growth hormone therapy on quality of life in adults with turner syndrome. J Clin Endocrinol Metab. 2010;95:1355–9.
Bolar K, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in turner syndrome. J Clin Endocrinol Metab. 2008;93:344–51.
Matura LA, Sachdev V, Bakalov VK, Rosing DR, Bondy CA. Growth hormone treatment and left ventricular dimensions in Turner syndrome. J Pediatr. 2007;150:587–91.
van den Berg J, Bannink EM, Wielopolski PA, et al. Cardiac status after childhood growth hormone treatment of Turner syndrome. J Clin Endocrinol Metab. 2008;93:2553–8.
Joss EE, Zurbrugg RP, Tonz O, Mullis PE. Effect of growth hormone and oxandrolone treatment on glucose metabolism in Turner syndrome. A longitudinal study. Horm Res. 2000;53:1–8.
Saenger P. Metabolic consequences of growth hormone treatment in paediatric practice. Horm Res. 2000;53 Suppl 1:60–9.
Sas T, de Muinck Keizer-Schrama S, Aanstoot HJ, Stijnen T, Drop S. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections. Clin Endocrinol (Oxf). 2000;52:741–7.
Wooten N, Bakalov VK, Hill S, Bondy CA. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab. 2008;93:2109–14.
Rosenfeld RG, Hintz RL, Johanson AJ, et al. Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. J Pediatr. 1988;113:393–400.
Cavallo L, Gurrado R. Endogenous growth hormone secretion does not correlate with growth in patients with Turner’s syndrome. Italian Study Group for Turner Syndrome. J Pediatr Endocrinol Metab. 1999;12:623–7.
Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, et al. Final height in girls with Turner’s syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone. Arch Dis Child. 1999;80:36–41.
Stool SE, Berg AO, Berman S et al. Quick reference guide for clinicans, managing otitis media with effusion in young children. Quick Reference Guide for Clinicans. AHCPR Publication No 94-0623 1994
Courant F, Aksglaede L, Antignac JP, et al. Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography-tandem mass spectrometry method. J Clin Endocrinol Metab. 2010;95:82–92.
Ankarberg-Lindgren C, Elfving M, Wikland KA, Norjavaara E. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab. 2001;86: 3039–44.
Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005;8 Suppl 1:3–63.
Mauras N, Shulman D, Hsiang HY, Balagopal P, Welch S. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome. J Clin Endocrinol Metab. 2007;92: 4154–60.
Nabhan ZM, Dimeglio LA, Qi R, Perkins SM, Eugster EA. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. J Clin Endocrinol Metab. 2009;94:2009–14.
Rosenfield RL, Perovic N, Devine N. Optimizing estrogen replacement in adolescents with Turner syndrome. Ann N Y Acad Sci. 2000;900: 213–4.
Zuckerman-Levin N, Frolova-Bishara T, Militianu D, Levin M, Aharon-Peretz J, Hochberg Z. Androgen replacement therapy in Turner syndrome: a pilot study. J Clin Endocrinol Metab. 2009;94: 4820–7.
Damiani D, Guedes DR, Fellous M, et al. Ullrich-Turner syndrome: relevance of searching for Y chromosome fragments. J Pediatr Endocrinol Metab. 1999;12:827–31.
Foudila T, Soderstrom-Anttila V, Hovatta O. Turner’s syndrome and pregnancies after oocyte donation. Hum Reprod. 1999;14:532–5.
Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Ben RZ. Turner’s syndrome and fertility: current status and possible putative prospects. Hum Reprod Update. 2001;7:603–10.
Boissonnas CC, Davy C, Bornes M, et al. Careful cardiovascular screening and follow-up of women with Turner syndrome before and during pregnancy is necessary to prevent maternal mortality. Fertil Steril. 2009;91:929.
Silberbach M. Susceptibility to aortic dissection in Turner Syndrome pregnancy: inadequacy of the ASRM Practice Committee Report. Fertil Steril. 2009;91:e33.
Boman UW, Moller A, Albertsson-Wikland K. Psychological aspects of Turner syndrome. J Psychosom Obstet Gynaecol. 1998;19:1–18.
Ross JL, Roeltgen D, Kushner H, Wei F, Zinn AR. The Turner syndrome-associated neurocognitive phenotype maps to distal Xp. Am J Hum Genet. 2000;67:672–81.
Davenport ML, Calikoglu AS. Turner syndrome. In: Pescovitz OH, Eugster EA, editors. Pediatric endocrinology: mechanisms, manifestations, and management. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. p. 203–23.
Russell KA. Orthodontic treatment for patients with Turner Syndrome. Am J Orthod Dentofacial Orthop. 2001. 120 (3): 314-22.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Davenport, M.L., Ross, J., Backeljauw, P.F. (2013). Turner Syndrome. In: Radovick, S., MacGillivray, M. (eds) Pediatric Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-395-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-60761-395-4_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-394-7
Online ISBN: 978-1-60761-395-4
eBook Packages: MedicineMedicine (R0)